These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10983629

  • 1. Plasma levels of vascular endothelial growth factor in patients with acromegaly.
    Nagai Y, Ando H, Nohara E, Yamashita H, Takamura T, Kobayashi K.
    Horm Metab Res; 2000 Aug; 32(8):326-9. PubMed ID: 10983629
    [Abstract] [Full Text] [Related]

  • 2. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH.
    Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
    [Abstract] [Full Text] [Related]

  • 3. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.
    Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991
    [Abstract] [Full Text] [Related]

  • 5. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 6. Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid).
    del Peso G, Selgas R, Bajo MA, Fernández de Castro M, Aguilera A, Cirugeda A, Jiménez C.
    Adv Perit Dial; 2000 Nov 01; 16():85-9. PubMed ID: 11045267
    [Abstract] [Full Text] [Related]

  • 7. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M, Akin F, Yaylali GF.
    Neuroendocrinology; 2007 Nov 01; 86(2):119-23. PubMed ID: 17671378
    [Abstract] [Full Text] [Related]

  • 8. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
    Exp Clin Endocrinol Diabetes; 2000 Nov 01; 108(7):486-92. PubMed ID: 11083070
    [Abstract] [Full Text] [Related]

  • 9. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct 01; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 10. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI.
    Clin Cancer Res; 2000 Aug 01; 6(8):3147-52. PubMed ID: 10955796
    [Abstract] [Full Text] [Related]

  • 11. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS, Musolino NR, Salgado LR, Bronstein MD.
    Clin Endocrinol (Oxf); 2005 Aug 01; 63(2):168-75. PubMed ID: 16060910
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
    George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW, Cancer and Leukemia Group B 9480.
    Clin Cancer Res; 2001 Jul 01; 7(7):1932-6. PubMed ID: 11448906
    [Abstract] [Full Text] [Related]

  • 13. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
    Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC, Fogler WE, Turner EM, Alexander HR, Libutti SK.
    Clin Cancer Res; 2000 Dec 01; 6(12):4628-34. PubMed ID: 11156212
    [Abstract] [Full Text] [Related]

  • 14. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P, Orpana A, Joensuu H.
    Clin Cancer Res; 1999 Mar 01; 5(3):487-91. PubMed ID: 10100697
    [Abstract] [Full Text] [Related]

  • 15. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
    Chen CA, Cheng WF, Lee CN, Chen TM, Kung CC, Hsieh FJ, Hsieh CY.
    Gynecol Oncol; 1999 Aug 01; 74(2):235-40. PubMed ID: 10419737
    [Abstract] [Full Text] [Related]

  • 16. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
    Belgore FM, Blann AD, Lip GY.
    Clin Sci (Lond); 2001 May 01; 100(5):567-75. PubMed ID: 11294698
    [Abstract] [Full Text] [Related]

  • 17. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.
    Haematologica; 2000 Aug 01; 85(8):800-5. PubMed ID: 10942925
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J, Jankewicz J, Stepień H.
    Cytobios; 2000 Aug 01; 101(398):151-9. PubMed ID: 10755214
    [Abstract] [Full Text] [Related]

  • 19. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
    Bielohuby M, Roemmler J, Manolopoulou J, Johnsen I, Sawitzky M, Schopohl J, Reincke M, Wolf E, Hoeflich A, Bidlingmaier M.
    Exp Biol Med (Maywood); 2009 Aug 01; 234(8):1002-9. PubMed ID: 19491373
    [Abstract] [Full Text] [Related]

  • 20. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Macut D, Vukojevic P, Joksimovic MM.
    Clin Endocrinol (Oxf); 2005 Apr 01; 62(4):410-7. PubMed ID: 15807870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.